Activation of human eosinophils via P2 receptors: Novel findings and future perspectives

Journal of Leukocyte Biology

Volumn 79, Issue 1, 2006, Pages 7-15

  Ferrari, Davide ^a   La Sala, Andrea ^b   Panther, Elisabeth ^c   Norgauer, Johannes ^d   Di Virgilio, Francesco ^a   Idzko, Marco ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Extracellular nucleotides; Inflammation

Indexed keywords

CHLORIDE; NUCLEOTIDE; PURINE P2 RECEPTOR;

BACTERIAL INFECTION; CELL DAMAGE; CELL MEMBRANE; CELL TYPE; CHLORIDE TRANSPORT; CILIARY MOTILITY; DEGRANULATION; EOSINOPHIL; GOBLET CELL; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; NERVE CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL INFECTIONS; CELL DEGRANULATION; CILIA; DENDRITIC CELLS; EOSINOPHILS; GENE EXPRESSION REGULATION; GOBLET CELLS; HUMANS; ION TRANSPORT; MAST CELLS; NEURONS; NUCLEOTIDES; RECEPTORS, PURINERGIC P2; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 30144445115     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0505286     Document Type: Review

References (161)

1. Gleich, G. J. (1990) Why do allergic individuals accumulate more eosinophils at the site of an IgE-mediated reaction than do normal subjects? Clin. Exp. Allergy 20, 245-246.
2. J. Allergy Clin. Immunol. 85, 422-436.
3. Bratton, D. L., Fadok, V. A. (1999) "Their's but to do and die": eosinophil longevity in asthma. J. Allergy Clin. Immunol. 103, 555-558.
4. Djukanovic, R., Roche, W. R., Wilson, J. W., Beasley, C. R., Twenty-man, O. P., Howarth, R. H., Holgate, S. T. (1990) Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142, 434-457.
5. Walsh, G. M. (1997) Mechanisms of human eosinophil survival and apoptosis. Clin. Exp. Allergy 27, 482-487.
6. Wong, C. K., Zhang, J., Ip, W. K., Lam, C. W. (2002) Intracellular signal transduction in eosinophils and its clinical significance. Immunopharmacol. Immunotoxicol. 24, 165-186.
7. Lampinen, M., Carlson, M., Hakansson, L. D., Venge, P. (2004) Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 39, 793-805.
8. Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255.
9. Burnstock, G. (1975) Comparative studies of purinergic nerves. J. Exp. Zool. 194, 103-133.
10. Burgers, J. A., Schweizer, R. C., Koenderman, L., Bruijnzeel, P. L., Akkerman, J. W. (1993) Human platelets secrete chemotactic activity for eosinophils. Blood 81, 49-55.
11. Jiang, Q., Mak, D., Devidas, S., Schwiebert, E. M., Bragin, A., Zhang, Y., Skach, W. R., Guggino, W. B., Foskett, J. K., Engelhardt, J. F. (1998) Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor. J. Cell Biol. 143, 645-657.
12. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., Di Virgilio, F. (1997) Purinergic modulation of interleukin-1 β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582.
13. Kaczmarek, E., Koziak, K., Sevigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H., Robson, S. C. (1996) Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-33122.
14. 2+)-apyrase. J. Biol. Chem. 271, 9898-9901.
15. Zimmermann, H., Braun, N. (1999) Ecto-nucleotidases: molecular structures, catalytic properties and functional roles in the nervous system. Prog. Brain Res. 120, 371-385.
16. Ehrlich, P. (1879) Über die spezifischen granulationen des Blutes. Arch. Anat. Physiol. LPZ 3, 571.
17. Kulessa, H., Frampton, J., Graf, T. (1995) GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9, 1250-1262.
18. Yu, C., Cantor, A. B., Yang, H., Browne, C., Wells, R. A., Fujiwara, Y., Orkin, S. H. (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195, 1387-1395.
19. Hirasawa, R., Shimizu, R., Takahashi, S., Osawa, M., Takayanagi, S., Kato, Y., Onodera, M., Minegishi, N., Yamamoto, M., Fukao, K., Taniguchi, H., Nakauchi, H., Iwama, A. (2002) Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195, 1379-1386.
20. Gleich, G. J. (2000) Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105, 651-663.
21. Wardlaw, A. J. (1999) Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J. Allergy Clin. Immunol. 104, 917-926.
22. Linden, M., Svensson, C., Andersson, M., Greiff, L., Andersson, E., Denburg, J. A., Persson, C. G. (1999) Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy 54, 212-219.
23. Denburg, J. A., Sehmi, R., Saito, H., Pil-Seob, J., Inman, M. D., O'Byrne, P. M. (2000) Systemic aspects of allergic disease: bone marrow responses. J. Allergy Clin. Immunol. 106 (Suppl. 5), S242-S246.
24. Gauvreau, G. M., Wood, L. J., Sehmi, R., Watson, R. M., Dorman, S. C., Schleimer, R. P., Denburg, J. A., O'Byrne, P. M. (2000) The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Am. J. Respir. Crit. Care Med. 162, 2139-2144.
25. Rothenberg, M. E. (1998) Eosinophilia. N. Engl. J. Med. 338, 1592-1600.
26. Hogan, S. P., Mould, A. W., Young, J. M., Rothenberg, M. E., Ramsay, A. J., Matthaei, K., Young, I. G., Foster, P. S. (1998) Cellular and molecular regulation of eosinophil trafficking to the lung. Immunol. Cell Biol. 76, 454-460.
27. Bochner, B. S., Schleimer, R. P. (2001) Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol. Rev. 179, 5-15,
28. Davenpeck, K. L., Bochner, B. S. (2002) Leukocyte-blood vessel interactions. Clin. Allergy Immunol. 16, 125-141.
29. Wardlaw, A. J., Moqbel, R., Kay, A. B. (1995) Eosinophils: biology and role in disease. Adv. Immunol. 60, 151-266.
30. Rothenberg, M. E. (1999) Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21, 291-295.
31. Silberstein, D. S. (1995) Eosinophil function in health and disease. Crit. Rev. Oncol. Hematol. 19, 47-77.
32. Broide, D., Sriramarao, P. (2001) Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179, 163-172.
33. Foster, P. S., Mould, A. W., Yang, M., Mackenzie, J., Mattes, J., Hogan, S. P., Mahalingam, S., Mckenzie, A. N., Rothenberg, M. E., Young, I. G., Matthaei, K. I., Webb, D. C. (2001) Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179, 173-181.
34. Kweon, M. N., Yamamoto, M., Kajiki, M., Takahashi, I., Kiyono, H. (2000) Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J. Clin. Invest. 106, 199-206.
35. Broide, D. H., Campbell, K., Gifford, T., Sriramarao, P. (2000) Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium. Blood 95, 263-269.
36. Wang, S., Fan, Y., Han, X., Yang, J., Bilenki, L., Yang, X. (2001) IL-12-dependent vascular cell adhesion molecule-1 expression contributes to airway eosinophilic inflammation in a mouse model of asthma-like reaction. J. Immunol. 166, 2741-2749.
37. Wang, J., Homer, R. J., Chen, Q., Elias, J. A. (2000) Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165, 4051-4061.
38. Wang, J., Homer, R. J., Hong, L., Cohn, L., Lee, C. G., Jung, S., Elias, J. A. (2000) IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J. Immunol. 165, 2222-2231.
39. Lukacs, N. W. (2001) Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 1, 108-116.
40. Lynch, O. T., Giembycz, M. A., Daniels, I., Barnes, P. J., Lindsay, M. A. (2000) Pleiotropic role of lyn kinase in leukotriene B(4)-induced eosinophil activation. Blood 95, 3541-3547.
41. Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., Nagata, K. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193, 255-261.
42. Elsner, J., Dichmann, S., Kapp, A. (1995) Activation of the respiratory burst in human eosinophils by chemotaxins requires intracellular calcium fluxes. J. Invest. Dermatol. 105, 231-236.
43. Takafuji, S., Bischoff, S. C., De Weck, A. L., Dahinden, C. A. (1991) IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J. Immunol. 147, 3855-3861.
44. Rothenberg, M. E., Owen Jr., W. F., Silberstein, D. S., Soberman, R. J., Austen, K. F., Stevens, R. L. (1987) Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 237, 645-647.
45. Tomioka, K., MacGlashan Jr., D. W., Lichtenstein, L. M., Bochner, B. S., Schleimer, R. P. (1993) GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. J. Immunol. 151, 4989-4997.
46. Petering, H., Kohl, J., Weyergraf, A., Dulkys, Y., Kimmig, D., Smolarski, R., Kapp, A., Elsner, J. (2000) Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a. J. Immunol. 164, 3783-3789.
47. Petering, H., Hochstetter, R., Kimmig, D., Smolarski, R., Kapp, A., Elsner, J. (1998) Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J. Immunol. 160, 555-558.
48. Dahinden, C. A., Zingg, J., Maly, F. E., de Weck, A. L. (1988) Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and fMLP as second signals. J. Exp. Med. 167, 1281-1295.
49. Agrawal, D. K., Sarmiento, E. U., Nabe, M., Miyagawa, H., Townley, R. G. (1996) Increased hypodense eosinophils after activation with PAF-acether and calcium ionophore in asthmatic subjects. J. Asthma 33, 213-219.
50. Gounni, A. S., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J. P., Capron, M. (1994) High affinitiy IgE receptor on eosinphils is involved in defense against parasites. Nature 367, 183-186.
51. Seminario, M. C., Saini, S. S., Mac Glashan Jr., D. W., Bochner, B. S. (1999) Intracellular expression and release of Fc ε RI α by human eosinophils. J. Immunol. 162, 6893-6900.
52. Kita, H., Kaneko, M., Bartemes, K. R., Weiler, D. A., Schimming, A. W., Reed, C. E., Gleich, C. J. (1999) Does IgE bind to and activate eosinophils from patients with allergy? J. Immunol. 162, 6901-6911.
53. Frigas, E., Gleich, G. J. (1986) The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77, 527-537.
54. Elsner, J., Kapp, A. (1999) Regulation and modulation of eosinophil effector functions. Allergy 54, 15-26.
55. Filley, W. V., Holley, K. E., Kephart, G. M., Gleich, G. J. (1982) Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2, 11-16.
56. Torpier, G., Colombel, J. F., Mathieu-Chandelier, C., Capron, M., Dessaint, J. P., Cortot, A., Paris, J. C., Capron, A. (1988) Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin. Exp. Immunol. 74, 404-408.
57. Keshavarzian, A., Saverymuttu, S. H., Tai, P. C., Thompson, M., Barter, S., Spry, C. J., Chadwick, V. S. (1985) Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 88, 1041-1049.
58. Hill, S. M., Milla, P. J. (1990) Colitis caused by food allergy in infants. Arch. Dis. Child. 65, 132-133.
59. Furuta, G. T. (1998) Eosinophils in the esophagus: acid is not the only cause. J. Pediatr. Gastroenterol. Nutr. 26, 468-471.
60. Hagan, P., Wilkins, H. A., Blumenthal, U. J., Hayes, R. J., Greenwood, B. M. (1985) Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7, 625-632.
61. Klion, A. D., Nutman, T. B. (2004) The role of eosinophils in host defense against helminth parasites. J. Allergy Clin. Immunol. 113, 30-37.
62. Dvorak, A. M. (1980) Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. J. Immunol. 125, 460-462.
63. Rothenberg, M. E., Mishra, A., Brandt, E. B., Hogan, S. P. (2001) Gastrointestinal eosinophils. Immunol. Rev. 179, 139-155.
64. Gleich, G. J., Frigas, E., Loegering, D. A., Wassom, D. L., Steinmuller, D. (1979) Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123, 2925-2927.
65. Gleich, G. J., Schroeter, A. L., Marcoux, J. P., Sachs, M. I., O'Connell, E. J., Kohler, P. F. (1984) Episodic angioedema associated with eosinophilia. N. Engl. J. Med. 310, 1621-1626.
66. Costa, J. J., Weller, P. F., Galli, S. J. (1997) The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278, 1815-1822.
67. Slifman, N. R., Loegering, D. A., McKean, D. J., Gleich, G. J. (1986) Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137, 2913-2917.
68. Rosenberg, H. F., Dyer, K. D., Tiffany, H. L., Gonzalez, M. (1995) Rapid evolution of a unique family of primate ribonuclease genes. Nat. Genet. 10, 219-223.
69. Young, J. D., Peterson, C. G., Venge, P., Cohn, Z. A. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321, 613-616.
70. Piliponsky, A. M., Pickholtz, D., Gleich, G. J., Levi-Schaffer, F. (2001) Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J. Allergy Clin. Immunol. 107, 993-1000.
71. Lewis, R. A., Austen, K. F., Soberman, R. J. (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323, 645-655.
72. Shaw, R. J., Walsh, G. M., Cromwell, O., Moqbel, R., Spry, C. J., Kay, A. B. (1985) Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature 316, 150-152.
73. Cromwell, O., Wardlaw, A. J., Champion, A., Moqbel, R., Osei, D., Kay, A. B. (1990) IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J. Immunol. 145, 3862-3868.
74. Kita, H. (1996) The eosinophil: a cytokine-producing cell? J. Allergy Clin. Immunol. 97, 889-892.
75. Bochner, B. S. (2000) Systemic activation of basophils and eosinophils: markers and consequences. J. Allergy Clin. Immunol. 106 (Suppl. 5), S292-S302.
76. Lee, N. A., Gelfand, E. W., Lee, J. J. (2001) Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J. Allergy Clin. Immunol. 107, 945-957.
77. Shi, H. Z. (2004) Eosinophils function as antigen-presenting cells. J. Leukoc. Biol. 76, 520-527.
78. + T-cell proliferation. Immunology 81, 584-591.
79. Adamko, D., Lacy, P., Moqbel, R. (2004) Eosinophil function in allergic inflammation: from bone marrow to tissue response. Curr. Allergy Asthma Rep. 4, 149-158.
80. Corrigan, C. J., Kay, A. B. (1992) T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13, 501-507.
81. Ascensao, J. L., Oken, M. M., Ewing, S. L., Goldberg, R. J., Kaplan, M. E. (1987) Leukocytosis and large cell lung cancer. A frequent association. Cancer 60, 903-905.
82. Lacy, P. D., Piccirillo, J. F. (1998) Development of a new staging system for patients with recurrent laryngeal squamous cell carcinoma. Cancer 83, 910-917.
83. Dorta, R. G., Landman, G., Kowalski, L. P., Lauris, J. R., Latorre, M. R., Oliveira, D. T. (2002) Tumor-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 41, 152-157.
84. Takanami, I., Takeuchi, K., Gika, M. (2002) Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. Anticancer Res. 22, 2391-2396.
85. Abbracchio, M. P., Burnstock, G. (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64, 445-475.
86. Dubyak, G. R., el-Moatassim, C. (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265, C577-C606.
87. North, R. A., Surprenant, A. (2000) Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40, 563-580.
88. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., Baricordi, O. R. (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587-600.
89. Muller, C. E. (2002) P2-pyrimidinergic receptors and their ligands. Curr. Pharm. Des. 8, 2353-2369.
90. Apasov, S., Koshiba, M., Redegeld, F., Sitkovsky, M. V. (1995) Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol. Rev. 146, 5-19.
91. Ralevic, V., Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
92. von Kugelgen, I., Wetter, A. (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362, 310-323.
93. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., Baricordi, O. R. (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587-600.
94. Lee, B. C., Cheng, T., Adams, G. B., Attar, E. C., Miura, N., Lee, S. B., Saito, Y., Olszak, I., Dombkowski, D., Olson, D. P., Hancock, J., Choi, P. S., Haber, D. A., Lustre, A. D., Scadden, D. T. (2003) P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bonemarrow hematopoietic stem cells. Genes Dev. 17, 1592-1604.
95. Leon, C., Freund, M., Ravanat, C., Baurand, A., Cazenave, J. P., Gachet, C. (2001) Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 103, 718-723.
96. Cressman, V. L., Lazarowski, E., Homolya, L., Boucher, R. C., Koller, B. H., Grubb, B. R. (1999) Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(-) transport. J. Biol. Chem. 274, 26461-26468.
97. 96. Southey, M. C., Hammet, F., Hutchins, A. M., Paidhungat, M., Somers, G. R., Venter, D. J. (1996) Molecular cloning and sequencing of a novel human P2 nucleotide receptor. Biochim. Biophys. Acta 1309, 77-80.
98. Maier, R., Glatz, A., Mosbacher, J., Bilbe, G. (1997) Cloning of P2Y6 cDNAs and identification of a pseudogene: comparison of P2Y receptor subtype expression in bone and brain tissues. Biochem. Biophys. Res. Commun. 240, 298-302.
99. 11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166, 7172-7177.
100. Conigrave, A. D., Fernando, K. C., Gu, B., Tasevski, V., Zhang, W., Luttrell, B. M., Wiley, J. S. (2001) P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur. J. Pharmacol. 426, 157-163.
101. Nguyen, T. D., Meichle, S., Kim, U. S., Wong, T., Moody, M. W. (2001) P2Y(11), a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G795-G804.
102. Schnurr, M., Toy, T., Stoitzner, P., Cameron, P., Shin, A., Beecroft, T., Davis, I. D., Cebon, J., Maraskovsky, E. (2003) ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102, 613-620.
103. Chhatriwala, M., Ravi, R. G., Patel, R. I., Boyer, J. L., Jacobson, K. A., Harden, T. K. (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J. Pharmacol. Exp. Ther. 311, 1038-1043.
104. Wihlborg, A. K., Wang, L., Braun, O. O., Eyjolfsson, A., Gustafsson, R., Gudbjartsson, T., Erlinge, D. (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler. Thromb. Vasc. Biol. 24, 1810-1815.
105. 12 receptor signaling play a crucial role in thrombin-induced ERK2 activation in human platelets. Thromb. Haemost. 92, 114-123.
106. Communi, D., Gonzalez, N. S., Detheux, M., Brezillon, S., Lannoy, V., Parmentier, M., Boeynaems, J. M. (2001) Identification of a novel human ADP receptor coupled to G(i). J. Biol. Chem. 276, 41479-41485.
107. Wang, L., Olivecrona, G., Gotberg, M., Olsson, M. L., Winzell, M. S., Erlinge, D. (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ. Res. 96, 189-196.
108. Skelton, L., Cooper, M., Murphy, M., Platt, A. (2003) Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. J. Immunol. 171, 1941-1949.
109. Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J. M. (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase and adenylyl cyclase. J. Biol. Chem. 272, 31969-31973.
110. Schachter, J. B., Li, Q., Boyer, J. L., Nicholas, R. A., Harden, T. K. (1996) Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118, 167-173.
111. van der Weyden, L., Adams, D. J., Luttrell, B. M., Conigrave, A. D., Morris, M. B. (2000) Pharmacological characterization of the P2Y11 receptor in stably transfected haematological cell lines. Mol. Cell. Biochem. 213, 75-81.
112. Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma Jr., F. J., Wiekowski, M. T., Abbondanzo, S. J., Cook, D. N., Bayne, M. L., Lira, S. A., Chintala, M. S. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107, 1591-1598.
113. Ralevic, V., Burrell, S., Kingdom, J., Burnstock, G. (1997) Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons. Br. J. Pharmacol. 121, 1121-1126.
114. Nicholas, R. A., Lazarowski, E. R., Watt, W. C., Li, Q., Boyer, J., Harden, T. K. (1996) Pharmacological and second messenger signalin selectivities of cloned P2Y receptors. J. Auton. Pharmacol. 16, 319-323.
115. 4 receptor. Eur. J. Pharmacol. 317, 383-389.
116. Abbracchio, M. P., Boeynaems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., Miras-Portugal, M. T., King, B. F., Gachet, C., Jacobson, K. A., Weisman, G. A., Burnstock, G. (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci. 24, 52-55.
117. Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L., Murdock, P., McMillan, L., Trill, J., Swift, A., Aiyar, N., Taylor, P., Vawter, L., Naheed, S., Szekeres, P., Hervieu, G., Scott, C., Watson, J. M., Murphy, A. J., Duzic, E., Klein, C., Bergsma, D. J., Wilson, S., Livi, G. P. (2000) A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 275, 10767-10771.
118. Bianco, F., Fumagalli, M., Pravettoni, E., D'Ambrosi, N., Volonte, C., Matteoli, M., Abbracchio, M. P., Verderio, C. (2005) Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res. Brain Res. Rev. 48, 144-156.
119. Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q., Harden, K. (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol. Pharmacol. 50, 224-229.
120. Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., Buell, G. (1994) A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371, 516-519.
121. North, R. A., Surprenant, A. (2000) Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40, 563-580.
122. Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., Venketaraman, V., Baricordi, O. R. (1998) Cytolytic P2X purinoceptors. Cell Death Differ. 5, 191-199.
123. MacKenzie, A. B., Mahaut-Smith, M. P., Sage, S. O. (1996) Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J. Biol. Chem. 271, 2879-2881.
124. Ferrari, D., La Sala, A., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., Di Virgilio, F. (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 14, 2466-2476.
125. Seyffert, C., Schmalzing, G., Markwardt, F. (2004) Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors. Curr. Top. Med. Chem. 4, 1719-1730.
126. Jiang, L., Bardini, M., Keogh, A., dos Remedios, C. G., Burnstock, G. (2005) P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. Int. J. Cardiol. 98, 291-297.
127. Lemoli, R. M., Ferrari, D., Fogli, M., Rossi, L., Pizzirani, C., Forchap, S., Chiozzi, P., Vaselli, D., Bertolini, F., Foutz, T., Aluigi, M., Baccarani, M., De Virgilio, F. (2004) Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 104, 1662-1670.
128. Chen, C. C., Akopian, A. N., Sivilotti, L., Colquhoun, D., Burnstock, G., Wood, J. N. (1995) A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377, 428-431.
129. North, R. A. (2003) The P2X3 subunit: a molecular target in pain therapeutics. Curr. Opin. Investig. Drugs 4, 833-840.
130. Bo, X., Zhang, Y., Nassar, M., Burnstock, G., Schoepfer, R. (1995) A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375, 129-133.
131. Wang, L., Jacobsen, S. E., Bengtsson, A., Erlinge, D. (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol. 5, 16.
132. Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., Buell, G. (1996) Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16, 2495-2507.
133. Greig, A. V., Linge, C., Cambrey, A., Burnstock, G. (2003) Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J. Invest. Dermatol. 121, 1145-1149.
134. Caraccio, N., Monzani, F., Santini, E., Cuccato, S., Ferrari, D., Callegari, M. G., Mulinelli, S., Pizzirani, C., Di Virgilio, F., Ferrannini, E., Solini, A. (2005) Extracellular ATP modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology. 146, 3172-3178.
135. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., Buell, G. (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738.
136. Di Virgilio, F. (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16, 524-528.
137. 7 receptor. Curr. Top. Med. Chem. 4, 1707-1717.
138. Saito, H., Ebisawa, M., Reason, D. C., Ohno, K., Kurihara, K., Sakaguchi, N., Ohgimi, A., Saito, E., Akasawa, A., Akimoto, K., et al. (1991) Extracellular ATP stimulates interleukin-dependent cultured mast cells and eosinophils through calcium mobilization. Int. Arch. Allergy Appl. Immunol. 94, 68-70.
139. Ferrari, D., Idzko, M., Dichmann, S., Purlis, D., Virchow, C., Norgauer, J., Chiozzi, P., Di Virgilio, F., Luttmann, W. (2000) P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. FEBS Lett. 486, 217-224.
140. 2+ in human eosinophils: activation of purinergic P2Y receptors. J. Allergy Clin. Immunol. 107, 849-855.
141. Idzko, M., Dichmann, S., Panther, E., Ferrari, D., Herouy, Y., Virchow Jr., C., Luttmann, W., Di Virgilio, F., Norgauer, J. (2001) Functional characterization of P2Y and P2X receptors in human eosinophils. J. Cell. Physiol. 188, 329-336.
142. Dichmann, S., Idzko, M., Zimpfer, U., Hofmann, C., Ferrari, D., Luttmann, W., Virchow Jr., C., Di Virgilio, F., Norgauer, J. (2000) Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. Blood 95, 973-978.
143. 2+ mobilization, and actin reorganization in human eosinophils via pertussis toxin-sensitive G proteins. J. Immunol. 172, 4480-4485.
144. Norgauer, J., Eberle, M., Fay, S. P., Lemke, H. D., Sklar, L. A. (1991) Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils. J. Immunol. 146, 975-980.
145. Walker, C., Rihs, S., Braun, R. K., Betz, S., Bruijnzeel, P. L. (1993) Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J. Immunol. 150, 4061-4071.
146. Olsson, I., Venge, P., Spitznagel, J. K., Lehres, R. I. (1977) Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab. Invest. 36, 493-500.
147. Maeda, T., Kitazo, E. M., Tada, H., De Llorens, R., Salomon, D. S., Ueda, M., Yamada, H., Seno, M. (2002) Growth inhibition of mammalian cells by eosinophil cationic protein. Eur. J. Biochem. 269, 307-316.
148. Pronk-Admiraal, C. J., Bartels, P. C. (2001) Total amount of ECP per eosinophil as indicator for the activity state of eosinophils. Scand. J. Clin. Lab. Invest. 61, 453-457.
149. Sugihara, R., Kumamoto, T., Ito, T., Ueyama, H., Toyoshima, I., Tsuda, T. (2001) Human muscle protein degradation in vitro by eosinophil cationic protein (ECP). Muscle Nerve 24, 1627-1634.
150. Yousefi, S., Hemmann, S., Weber, M., Holzer, C., Hartung, K., Blaser, K., Simon, H. U. (1995) IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J. Immunol. 154, 5481-5490.
151. Idzko, M., Panther, E., Bremer, H. C., Sorichter, S., Luttmann, W., Virchow Jr., C. J., Di Virgilio, F., Herouy, Y., Norgauer, J., Ferrari, D. (2003) Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils. Br. J. Pharmacol. 138, 1244-1250.
152. Shin, C. Y., Kim, K. C., Lee, W. J., Jo, M. J., Park, K. H., Dalby, R., Ko, K. H. (2000) Inhaled ATP causes mucin release from goblet cells of intact rats. Exp. Lung Res. 26, 1-11.
153. Forsythe, P., Ennis, M. (1999) Adenosine, mast cells and asthma. Inflamm. Res. 48, 301-307.
154. Donaldson, S. H., Picher, M., Boucher, R. C. (2002) Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am. J. Respir. Cell Mol. Biol. 26, 209-215.
155. Pellegrino, R., Wilson, O., Jenouri, G., Rodarte, J. R. (1996) Lung mechanics during induced bronchoconstriction. J. Appl. Physiol. 81, 964-975.
156. Pelleg, A., Schulman, E. S. (2002) Adenosine 5′-triphosphate axis in obstructive airway diseases. Am. J. Ther. 9, 454-464.
157. Schulman, E. S., Glaum, M. C., Post, T., Wang, Y., Raible, D. G., Mohanty, J., Butterfield, J. H., Pelleg, A. (1999) ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am. J. Respir. Cell Mol. Biol. 20, 530-537.
158. Weller, P. F., Goetzl, E. J. (1980) The human eosinophil: roles in host defense and tissue injury. Am. J. Pathol. 100, 791-820.
159. Coffey, R. G., Hadden, J. W., Middleton Jr., E. (1974) Increased adenosine triphosphatase in leukocytes of asthmatic children. J. Clin. Invest. 54, 138-146.
160. Mue, S., Ise, T., Shibahara, S., Takahashi, M., Takishima, T. (1976) Leukocyte adenosine triphosphatase activity in human bronchial asthma. Tohoku J. Exp. Med. 119, 257-264.
161. Olivier, K. N., Bennett, W. D., Hohneker, K. W., Zeman, K. L., Edwards, L. J., Boucher, R. C., Knowles, M. R. (1996) Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate +/- amiloride in normal human adults. Am. J. Respir. Crit. Care Med. 154, 217-223.